I've covered these dividend winners before, but you're not too late to get on board.
Its potent hepatitis C treatment is not a boon for shareholders.
Benchmarks ended higher on Tuesday boosted by better-than-expected corporate results
Merck and Award-Winning Actress S. Epatha Merkerson Challenge Americans with Type 2 Diabetes to Get to Their GoalsPR Newswire 04/23 08:00 ET
WHITEHOUSE STATION, N.J., April 23, 2014 /PRNewswire/ -- Merck (MRK), known as MSD outside the United States and Canada, today announced it is teaming up with Emmy and Golden Globe-winning actress S. Epatha Merkerson on America's Diabetes Challenge: Get to Your Goals, an educational program intended to encourage people with type 2 diabetes to achieve better control of their blood sugar -- a key goal to help reduce the risk of serious health problems. Merkerson, who lives with type 2 diabetes, will travel the country urging people to know their A1C (average blood sugar level over the past two to three months) and to work with their doctors to set and attain their own A1C goal. Nearly half of people with diabetes have an A1C greater than 7 percent, but the American Diabetes Association recommends that many people with diabetes should have an A1C of less than 7 percent to help reduce the risk of complications.
Benchmarks ended in the green zone yesterday as investors were encouraged by better-than-expected corporate earnings results
LONDON--GlaxoSmithKline PLC's (GSK) decision to leave the hot field of cancer drugs narrows the focus of its business to just four areas: respiratory and HIV treatments, vaccines and consumer-health products.